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Abstract
Challenges	 intrinsic	 to	 the	 accurate	 diagnosis	 of	 endometriosis	 contribute	 to	 an	
extended	 delay	 between	 the	 onset	 of	 symptoms	 and	 clinical	 confirmation.	
Intraoperative	visualization,	 preferably	with	histologic	 verification,	 is	 considered	by	
many	professional	organizations	 to	be	 the	gold	standard	by	which	endometriosis	 is	
diagnosed.	Clinical	diagnosis	of	symptomatic	endometriosis	via	patient	history,	physi-
cal	 examination,	 and	 noninvasive	 tests,	 though	 more	 easily	 executed,	 is	 generally	
viewed	as	less	accurate	than	surgical	diagnosis.	Technological	advances	and	increased	
understanding	of	the	pathophysiology	of	endometriosis	warrant	continuing	reevalua-
tion	of	the	standard	method	for	diagnosing	symptomatic	disease.	A	review	of	the	pub-
lished	literature	was	therefore	performed	with	the	goal	of	comparing	the	accuracy	of	
clinical	diagnostic	measures	with	that	of	surgical	diagnosis.	The	current	body	of	evi-
dence	suggests	that	clinical	diagnosis	of	symptomatic	endometriosis	is	more	reliable	
than	previously	 recognized	and	that	surgical	diagnosis	has	 limitations	that	could	be	
underappreciated.	Regardless	of	the	methodology	used,	women	with	suspected	symp-
tomatic	endometriosis	would	be	well	served	by	a	diagnostic	paradigm	that	is	reliable,	
conveys	minimal	 risk	 of	 under-	 or	 over-	diagnosis,	 lessens	 the	 time	 from	 symptom	
development	 to	 diagnosis,	 and	 guides	 the	 appropriate	 use	 of	medical	 and	 surgical	
management	strategies.
K E Y W O R D S
Diagnosis;	Endometriosis;	Histology;	Infertility;	Laparoscopy;	Pelvic	examination;	 
Pelvic	pain;	Surgery
1  | INTRODUCTION
Endometriosis	is	a	common	gynecologic	condition	that	affects	approx-
imately	 6%–10%	 of	 reproductive-	aged	 women.1	 Pain,	 a	 frequent	
symptom	of	endometriosis	that	manifests	as	dysmenorrhea,	chronic	
pelvic	 pain,	 dyspareunia,	 and/or	 dyschezia,	 can	 be	 debilitating.	
Even	 among	women	without	 extensive	 disease,	 pain	 can	 limit	 daily	
life	activities	and	negatively	affect	health-	related	quality	of	 life	and	
This	is	an	open	access	article	under	the	terms	of	the	Creative	Commons	Attribution-NonCommercial	License,	which	permits	use,	distribution	and	reproduction	in	any	
medium,	provided	the	original	work	is	properly	cited	and	is	not	used	for	commercial	purposes.
©	2018	The	Authors.	International Journal of Gynecology & Obstetrics	published	by	John	Wiley	&	Sons	Ltd	on	behalf	of	International	Federation	of	Gynecology	and	
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productivity,	with	 substantial	 economic	 consequences.2,3	 The	 other	
major	 sequela	 of	 endometriosis	 is	 infertility	 that,	 for	 some	women,	
is	the	only	indicator	of	the	disease.	Endometriosis	is	detected	among	
approximately	20%–50%	of	women	who	undergo	treatment	for	infer-
tility	and	who	do	not	present	with	symptoms	such	as	pain	or	men-
strual	irregularities.1
The	 profound	 influence	 of	 untreated	 endometriosis	 on	 many	
aspects	of	women’s	 lives	underscores	the	need	for	timely	diagno-
sis	and	 initiation	of	 treatment.	Nonetheless,	diagnostic	challenges	
coupled	with	 the	 requirement	 for	 surgical	 intervention	 to	make	 a	
diagnosis	often	result	in	considerable	delay	to	clinical	management	
of	 affected	 individuals.	 Studies	 that	 have	 evaluated	 the	 timing	 of	
diagnosis	in	various	parts	of	the	world	have	consistently	reported	a	
mean	or	median	interval	of	at	least	7	years	from	the	time	a	patient	
first	 experiences	 symptoms	 of	 endometriosis	 until	 she	 receives	 a	
confirmed	 diagnosis.2,4,5	 In	 the	 interim,	 many	women	with	 endo-
metriosis	 undergo	 consultations	 with	 multiple	 practitioners	 and	
receive	misdiagnoses	(e.g.	chronic	pelvic	pain	syndrome,	idiopathic	
sterility,	or	pelvic	inflammatory	disease)	before	finally	reaching	the	
correct	diagnosis.4
The	best	methods	 to	 diagnose	 endometriosis	 and	 to	 determine	
the	 extent	 and	 pathologic	 severity	 of	 this	 disease	 are	 subject	 to	
debate.1	Visualization—typically	by	laparoscopy	with	histologic	confir-
mation—is	generally	considered	to	be	the	gold	standard	(Table	1).1,6–9 
However,	 this	 technique	 is	 not	 without	 its	 limitations,	 costs,	 and	
risks.7,8	In	practice,	clinicians	often	rely	on	medical	history,	presenting	
symptoms,	and	findings	on	physical	examination	(i.e.	a	clinical	diagno-
sis),	with	or	without	imaging	studies,	as	the	basis	for	initiating	therapy.	
This	practice	is	consistent	with	guidance	from	the	American	College	
of	 Obstetricians	 and	 Gynecologists,1	 the	 Society	 of	 Obstetricians	
and	 Gynaecologists	 of	 Canada,7	 the	 European	 Society	 of	 Human	
Reproduction	and	Embryology8	 (also	endorsed	by	the	Royal	College	
of	Obstetricians	 and	Gynaecologists),	 and	 the	World	 Endometriosis	
Society	(WES).9	These	organizations	advocate	for	empiric	treatment	
before	 laparoscopy	 in	 selected	patients	 (Table	1).1,7–9	The	American	
Society	 for	 Reproductive	 Medicine	 (ASRM)	 guidelines	 state	 that	
laparoscopy	 before	 empiric	 treatment	 is	 the	 “preferred	 approach,	
although	 further	 studies	are	warranted”	 (Table	1).6	These	guidelines	
are	 predicated	 on	 the	 assumption	 that	 isolated	 clinical	 diagnosis	 is	
of	 limited	 accuracy.	 Nonetheless,	 as	 understanding	 of	 endometri-
osis	 increases	 and	 improved	 noninvasive	methods	 for	 its	 detection	
are	 developed,	 reevaluation	 of	 clinical	 diagnosis	 as	 a	viable,	 practi-
cal,	 reliable,	 and	widely	 accessible	 alternative	 to	 surgical	 diagnosis	
merits	consideration.
In	response	to	the	ongoing	question	of	clinical	versus	surgical	diag-
nosis	 for	endometriosis,	we	have	undertaken	a	critical	evaluation	of	
the	accuracy	of	both	approaches.	Relevant	published	data	were	iden-
tified	by	searching	the	MEDLINE	database	for	studies	that	described	
correlations	between	the	presence	of	endometriosis	and	symptoms,	
physical	findings,	 imaging	 studies,	or	 surgical	 and/or	histologic	find-
ings.	Given	the	limited	information	available	on	endometriosis	within	
the	adolescent	population,	our	discussion	will	focus	on	endometriosis	
among	adults,	unless	otherwise	indicated.
2  | ENDOMETRIOSIS 
DEFINITION AND STAGING
Any	discussion	of	the	diagnosis	of	endometriosis	must	begin	by	defin-
ing	what	constitutes	this	disease.	Endometriosis	is	traditionally	defined	
by	 the	 presence	 of	 lesions,	which	 vary	 considerably	 in	 appearance,	
size,	and	 location,	and	are	histologically	confirmed	by	the	detection	
of	endometrial	glands,	endometrial	stroma,	and/or	hemosiderin-	laden	
macrophages.	 However,	 an	 internationally	 accepted	 definition	 pro-
posed	 in	 2017	 describes	 endometriosis	 as	 “a	 disease	 characterized	
by	the	presence	of	endometrium-	like	epithelium	and	stroma	outside	
the	endometrium	and	myometrium.	Intrapelvic	endometriosis	can	be	
located	 superficially	 on	 the	 peritoneum	 (peritoneal	 endometriosis),	
can	 extend	 5	mm	or	more	 beneath	 the	 peritoneum	 (deep	 endome-
triosis),	or	can	be	present	as	an	ovarian	endometriotic	cyst	(endome-
trioma)”.10	These	definitions	are	based	solely	on	pathology	and	do	not	
consider	symptoms	such	as	pain	and	infertility	that	act	as	drivers	for	
the	initiation	of	treatment.	The	ability	to	diagnose	endometriosis	clini-
cally	requires	a	different	approach	in	which	symptoms	are	considered	
to	be	paramount	and	histology	is	a	secondary	criterion.	This	paradigm	
would	not	require	 imaging	or	 laparoscopy	for	diagnosis	unless	clini-
cally	indicated;	for	example,	in	the	presence	of	a	mass	or	findings	sus-
picious	for	malignancy.
Ambiguity	 is	 also	 found	 in	 the	 staging	 of	 endometriosis.	 A	
broadly	applicable	and	prognostically	relevant	classification	system	
for	 endometriosis	 has	 yet	 to	 be	 established.11	 Among	 the	 avail-
able	options,	the	revised	ASRM	(rASRM)	classification	and	staging	
system12	is	the	most	frequently	used	in	both	research	and	clinical	
practice.13	The	rASRM	system	uses	laparoscopic	findings	to	subdi-
vide	endometriosis	severity	into	four	stages:	I	(minimal),	II	(mild),	III	
(moderate),	and	IV	(severe).12	However,	the	stage	of	endometriosis	
does	 not	 necessarily	 correlate	with	 the	 severity	 of	 pain	 that	 the	
patient	experiences,	the	risk	of	 infertility,	or	other	outcomes	that	
are	 important	 to	patients	and	their	clinicians.11,14	The	disconnect	
between	rASRM	stage	and	pain	is	not	unexpected;	the	scale	used	
to	derive	 this	 classification	 system	had	been	designed	 to	predict	
the	efficacy	of	conservative	surgical	treatment	to	improve	fertility	
and	did	not	include	pain	as	an	outcome	variable.15	Indeed,	women	
with	 disease	 categorized	 as	 stage	 I	 or	 II	 can	 experience	 consid-
erable	 pain,	 infertility,	 or	 other	 endometriosis-	related	 symptoms,	
whereas	 severe	disease	has	 been	detected	 among	 asymptomatic	
women	who	undergo	laparoscopy	for	other	indications.16
The	use	of	“asymptomatic”	in	the	context	of	endometriosis	refers	
to	the	presence	of	endometrial	lesions	without	associated	pain,	infer-
tility,	ovarian	masses,	or	dysfunction	of	the	bladder	or	bowel.	Although	
the	 rASRM	classification	has	 the	advantages	of	being	 simple	 to	use	
and	easy	for	patients	to	understand,	the	caveats	discussed	above,	as	
well	 as	 its	 lack	of	utility	 in	 the	classification	of	deep	endometriosis,	
make	it	less	than	ideal.	A	newer	concept	is	to	categorize	endometriosis	
by	 its	 presentation:	 superficial,	 ovarian	 endometrioma,	 or	 deep	 dis-
ease.	Associations	have	been	made	between	symptom	presentation	
and	 endometriosis	 stratified	 into	 these	 three	 categories	 (discussed	
below	in	Section	3).17,18
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Given	the	limitations	of	individual	staging	systems,	the	2017	WES	con-
sensus	statement	recommends	the	use	of	a	“classification	toolbox”	that	
includes	the	rASRM	system	as	well	as	the	Enzian	and	the	Endometriosis	
Fertility	Index	classification	systems.11,19	The	WES	consensus	statement	
further	advocates	taking	steps	to	improve	the	classification	of	endometri-
osis,	particularly	for	cases	where	surgery	is	not	performed.
3  | CLINICAL DIAGNOSIS  
OF ENDOMETRIOSIS
Clinical	 presentations	 of	 endometriosis	 are	 highly	 diverse;	 none	 of	
the	 presenting	 signs	 or	 symptoms	 are	 pathognomonic	 for	 this	 dis-
ease.	 Because	 of	 the	 overlap	 in	 symptoms	with	 other	 gynecologic	
conditions	 (e.g.,	 primary	 dysmenorrhea,	 adenomyosis,	 pelvic	 adhe-
sions,	ovarian	cysts,	 pelvic	 inflammatory	disease)7	 and	chronic	pain	
syndromes	 (e.g.,	 irritable	 bowel,	 interstitial	 cystitis/painful	 bladder,	
fibromyalgia,	musculoskeletal	disorders),6	differential	diagnosis	 is	an	
important	 facet	 of	 identifying	 endometriosis.	 By	 way	 of	 example,	
gynecologic	 conditions	 such	 as	 primary	 dysmenorrhea,	 adenomyo-
sis,	pelvic	adhesions,	ovarian	cysts,	and	pelvic	 inflammatory	disease	
should	 be	 excluded,	 as	 should	 chronic	 pain	 syndromes,	 including	
irritable	bowel,	 interstitial	cystitis,	painful	bladder,	fibromyalgia,	and	
musculoskeletal	disorders.	Patient	and	family	history,	assessment	of	
pain	characteristics,	and	identification	of	menstrual	irregularities	can	
be	 informative	 for	 ruling	out	other	causes	of	pelvic	pain.	 Individual	
symptoms	may	 be	 informative	 in	 terms	 of	 assessing	 the	 likelihood	
that	 a	 patient	 has	 endometriosis	 but	 cannot,	 in	 and	of	 themselves,	
rule	endometriosis	in	or	out.
3.1 | Discriminatory value of pelvic pain
Pelvic	pain	is	a	common	occurrence	among	the	general	population.20 
Although	 pain	 is	 a	 cardinal	 symptom	 of	 endometriosis,	 discerning	
whether	 it	 can	be	 attributed	 to	 endometriosis	 is	 challenging.	 Pelvic	
pain	among	women	can	arise	from	a	variety	of	sources	and	have	multi-
ple	presentations	and	characteristics,	which	complicates	its	value	as	a	
marker	of	endometriosis.	As	shown	in	Table	2,	dysmenorrhea,	chronic	
pelvic	pain,	chronic	nonmenstrual	pelvic	pain,	and	dyspareunia	are	the	
most	consistently	reported	types	of	pain	among	women	with	endo-
metriosis.14,21–30	 Overall,	 dysmenorrhea	 is	 the	 most	 frequent	 pain	
symptom,	reported	by	the	majority	of	women	who	have	proven	endo-
metriosis.	Chronic	pelvic	pain	and/or	chronic	nonmenstrual	pelvic	pain	
are	 generally	 less	 common	 than	 dysmenorrhea,	 but	 are	 notable	 for	
their	higher	occurrence	rates	in	women	with	proven	or	self-	reported	
endometriosis	than	in	women	without	endometriosis.14,21,24,25,28
The	temporal	relationship	between	pain	and	the	menstrual	cycle	
can	 help	 to	 distinguish	 between	 primary	 and	 secondary	 dysmenor-
rhea,	the	latter	being	a	catch-	all	category	for	pain	caused	by	disorders	
of	 the	 reproductive	organs	 such	as	endometriosis.	Pelvic	pain	asso-
ciated	with	primary	dysmenorrhea	typically	occurs	with	the	onset	of	
menstrual	flow	and	lasts	for	approximately	8–72	hours.31	By	contrast,	
endometriosis	pain	is	progressive,	can	be	cyclic	or	acyclic,	and	could	
extend	beyond	the	3-	day	early	follicular-	phase	timeframe	associated	
with	primary	dysmenorrhea.	In	addition,	primary	dysmenorrhea	can	be	
differentiated	from	secondary	dysmenorrhea	by	its	rapid	response	to	
analgesia	with	nonsteroidal	anti-	inflammatory	drugs	(NSAIDs),	as	well	
as	the	non-	progressive	persistent	severity	of	the	pain	and	continued	
response	to	treatment	with	NSAIDs.6
Attempts	 to	 detect	 correlations	between	 the	 severity	 of	 disease	
(as	defined	by	the	volume,	location,	or	type	of	endometriotic	lesions)	
and	 the	 prevalence	 or	 severity	 of	 pain	 have	 produced	 disparate	
results.21,26,27,29	Although	a	study	by	Ashrafi	et	al.21	found	an	increased	
proportion	of	patients	who	reported	dysmenorrhea,	pelvic	pain,	and/
or	 dyspareunia	 among	 those	with	 stage	 III–IV	 versus	 stage	 I–II	 dis-
ease,	other	investigators	have	not	observed	such	a	correlation.14,26,27 
However,	it	is	important	to	note	that	the	population	studied	by	Ashrafi	
et	al.21	 comprised	 infertile	 women,	 who	 could	 be	 a	 physiologically	
different	 group	 than	 women	 with	 endometriosis	 who	 have	 never	
experienced	 infertility.	As	mentioned	above	 in	Section	2,	 the	rASRM	
classification	of	endometriosis	staging	was	not	designed	to	reflect	the	
degree	of	pain	that	a	patient	might	be	experiencing.
The	data	are	also	 inconsistent	 regarding	a	 link	between	 location	
of	 endometriosis	 and	 pain	 characteristics.14,27,28	 However,	 there	
does	seem	to	be	an	association	between	 the	 type	of	endometriosis	
and	pain	features.	Among	the	three	types	of	endometriosis	 (superfi-
cial	peritoneal	lesions,	ovarian	endometrioma,	and	deep	endometrio-
sis),	the	presence	of	deep	endometriosis	has	been	most	consistently	
linked	to	chronic	pelvic	pain.18	By	contrast,	superficial	lesions	are	less	
frequently	 associated	with	 pain	 and	 often	 observed	 among	 asymp-
tomatic	women.17	The	presence	of	ovarian	endometriomas	does	not	
correlate	with	dysmenorrhea	severity,	and	dysmenorrhea	is	less	com-
monly	associated	with	isolated	ovarian	endometriomas	compared	with	
other	disease	manifestations.18
The	available	evidence	confirms	that	women	with	endometriosis	
typically	experience	pain.	Although	the	occurrence	of	pelvic	pain	alone	
is	insufficient	to	diagnose	endometriosis	or	to	categorize	the	type	or	
stage	of	disease,	certain	characteristics	 (e.g.	dysmenorrhea,	progres-
sion,	and	insufficient	response	to	NSAIDs	or	oral	contraceptives)	are	
indicative	of	endometriosis.	It	is	important	to	note	that	the	prevalence	
of	endometriosis	 in	 asymptomatic	women	 is	not	 known.	Reports	of	
endometriosis	observed	at	 the	time	of	 laparoscopic	 tubal	 ligation	 in	
asymptomatic	women	are	limited,	and	what	reports	are	available	likely	
underestimate	 disease	 burden	 because	 the	 thoroughness	 of	 perito-
neal	surface	examination	is	typically	much	greater	in	symptomatic	ver-
sus	asymptomatic	women.
3.2 | Infertility as an indicator of endometriosis
Infertility	is	considerably	more	common	among	women	with	endome-
triosis	than	among	individuals	without	this	condition.	In	a	UK	case–
control	 study,	 women	 diagnosed	 with	 endometriosis	 were	 greater	
than	six	times	more	 likely	 to	have	a	history	of	 infertility	 than	were	
women	 without	 endometriosis.24	 Given	 this	 association,	 endome-
triosis	 should	be	 considered	 as	 a	 possible	 cause	of,	 or	 comorbidity	
among,	women	with	 infertility,	 particularly	 those	who	demonstrate	
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other	 symptoms	 consistent	 with	 endometriosis.	 Pain,	 menstrual	
irregularities,	 and	 fatigue	 (symptoms	 that	 are	 generally	 associated	
with	endometriosis)	have	been	shown	to	be	more	prevalent	among	
infertile	women	with	endometriosis	compared	with	infertile	women	
without	endometriosis.21
3.3 | Other symptomatic indicators of endometriosis
Studies	 evaluating	 risk	 factors	 or	 characteristics	 associated	 with	
endometriosis	have	reported	linkage	with	longer	duration	of	men-
ses,	 shorter	 menstrual	 cycle	 length,	 increased	 menstrual	 volume,	
irregular	 menstrual	 periods,	 post-	coital	 bleeding,	 and	 dysche-
zia,21,24,25,32	although	 the	findings	are	not	consistent.	Whereas	no	
single	 characteristic	 may	 reach	 significance	 as	 a	 prognostic	 fac-
tor	on	a	population	 level,	a	constellation	of	endometriosis-	related	
symptoms	 can	 be	 a	 strong	 indicator	 of	 disease.	 Indeed,	 Ballard	
et	al.24	 found	 that	 the	 likelihood	 of	 endometriosis	 increased	with	
the	 number	 of	 symptoms	 present,	with	 elevations	 in	 relative	 risk	
ranging	from	five-	fold	for	one	symptom	to	85-	fold	when	seven	or	
more	symptoms	were	present.
3.4 | Accuracy of physical examination as a 
diagnostic tool
Multiple	 studies	 have	 sought	 to	 quantify	 the	 ability	 of	 a	 physical	
examination	to	detect	endometriosis	by	gauging	its	accuracy	relative	
to	surgical	diagnosis	(Table	3).28,33–37	Patient	selection	and	examina-
tion	 methods	 differ	 among	 individual	 studies,	 which	 confound	 the	
overall	 estimation	 of	 accuracy.	 These	 limitations	 notwithstanding,	
the	specificity	(percentage	of	all	patients	without	surgically	confirmed	
endometriosis	who	have	a	negative	clinical	diagnosis),	positive	predic-
tive	value	 (PPV;	percentage	of	 all	 patients	with	 clinically	 diagnosed	
endometriosis	 that	 is	 surgically	 verified),	 and	 negative	 predictive	
value	 (NPV;	 percentage	 of	 all	 patients	 without	 clinically	 diagnosed	
TABLE  2 Common	pain	symptoms	among	women	with	endometriosis.a
Study (no. of patients) Population
Patients
Dysmenorrhea CPPb Dyspareunia
Ashrafi	et	al.	201621	(n=673) Infertile	women	with	laparoscopically	diagnosed	endometriosis 54–81c 31–52c 29–55c
Infertile	women	with	no	evidence	of	endometriosis	on	laparoscopy 41 19 20
Apostolopoulos	et	al.	201622	(n=96) Women	with	laparoscopically	diagnosed	endometriosis	but	without	
histologic	confirmation
67–89c 59–67c 24–41c
Schliep	et	al.	201514	(n=326) Women	with	laparoscopically	diagnosed	endometriosis 38–91 44 14–55
Women	with	a	laparoscopically	normal	pelvis 38–79 30 9–32
Bellelis	et	al.	201023	(n=892) Women	with	histologically	confirmed	endometriosis 28d 57 55
Ballard	et	al.	200824	(n=5540) Women	with	a	diagnosis	of	endometriosis 25e 16e 9e
Matched	control	individuals 3e 2e 1e
Flores	et	al.	200825	(n=1285) Women	with	self-	reported	endometriosis 83 80 52
Women	who	did	not	self-	report	endometriosis 59 23 20
Vercellini	et	al.	200726	(n=1054) Consecutive	women	with	endometriosis	undergoing	first-	line	
conservative	or	definitive	surgery
57f 30f 21f
GISE	200127	(n=469) Consecutive	women	with	pain	symptoms	lasting	≥6	mo	and	
laparoscopic	evidence	of	endometriosis	affecting	the	stated	
anatomic	sites
O: 77 O: 62 O:	39
P:	88 P:	57 P:	51
O&P:	92 O&P:	68 O&P:	51
RVS:	100 RVS:	67 RVS:	80
Eskenazi	et	al.	200128	(n=90) Women	with	surgically	confirmed	endometriosis 65 32 22
Women	with	no	evidence	of	endometriosis	on	laparoscopy	
or	laparotomy
30 15 23
Porpora	et	al.	1999	29	(n=90) Consecutive	women	with	histologically	confirmed	endometriosis 66 f 49 f 38	f
Forman	et	al.	199330	(n=99) Infertile	women	with	laparoscopically	diagnosed	endometriosis 53 20 23
Infertile	women	without	endometriosis 28 18 25
Abbreviations:	CPP,	chronic	pelvic	pain;	GISE,	Gruppo	Italiano	per	lo	Studio	dell’Endometriosi;	O,	ovary;	P,	peritoneum;	O&P,	ovary	and	peritoneum;	RVS,	
rectovaginal	septum.
aValues	are	given	as	percentages.
bIncludes	chronic	pelvic	pain	and	chronic	nonmenstrual	pelvic	pain.
cPercentage	varies	depending	on	the	disease	stage.
dPercentage	of	patients	experiencing	incapacitating	dysmenorrhea.
eReflects	the	prevalence	of	symptoms	recorded	in	patient	medical	records.
fPercentage	of	patients	experiencing	moderate	or	severe	pain	symptoms.
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endometriosis	who	are	also	surgically	negative)	of	a	physical	examina-
tion	are	generally	high	(80%–100%),	particularly	among	women	with	
a	strong	pretest	likelihood	of	disease	based	on	symptoms.	Sensitivity	
of	 physical	 examination	 (i.e.	 percentage	 of	 patients	 with	 clinically	
diagnosed	endometriosis	who	have	a	positive	surgical	 result)	shows	
a	greater	dependence	on	location	of	the	lesion	than	do	other	meas-
ures	of	diagnostic	accuracy.33–35	This	phenomenon	is	not	unexpected,	
given	that	the	ease	of	detecting	lesions	by	physical	examination	varies	
by	 their	 location.	The	 lower	values	 for	 sensitivity	 (18%–88%)	when	
compared	with	specificity	(46%–100%)	or	PPV	(40%–100%)	suggest	
that	 false-	negative	 physical	 examination	 findings	 occur	 more	 fre-
quently	than	do	false-	positive	findings.
4  | IMAGING STUDIES AS AN ADJUNCT TO 
CLINICAL DIAGNOSIS
The	data	described	above	in	Section	3.4	and	presented	in	Table	3	
reflect	 the	 results	 of	 physical	 examination	 alone,	 without	 the	
inclusion	of	other	measures	of	disease	detection	 (other	 than	his-
torical	symptoms	consistent	with	endometriosis).	In	addition,	they	
do	not	include	imaging	results,	which	have	increasingly	become	an	
integral	component	of	the	diagnostic	process	among	patients	with	
	suspected	endometriosis.
4.1 | Ultrasonography
Imaging	 methods	 such	 as	 ultrasonography	 have	 inherent	 value	 for	
their	ability	to	identify	causes	of	abdominal	pain	and	menstrual	symp-
toms	other	than	endometriosis	(e.g.	adenomyosis).	 In	the	context	of	
endometriosis,	 the	 addition	 of	 transvaginal	 ultrasonography	 (TVUS)	
to	pelvic	examination	increases	the	accuracy	of	a	clinical	diagnosis	of	
adnexal	and	rectal	disease.34	Hudelist	et	al.34	reported	almost	univer-
sal	increases	in	the	sensitivity	of	endometriosis	detection	when	TVUS	
was	 combined	 with	 pelvic	 examination	 versus	 pelvic	 examination	
alone	among	women	with	symptoms	suggestive	of	endometriosis.	Of	
note,	sensitivity	 for	detecting	ovarian	endometriosis	 increased	from	
approximately	30%	with	pelvic	examination	alone	to	greater	than	96%	
TABLE  3 Accuracy	of	physical	examination	in	diagnosing	endometriosis	for	patients	who	underwent	laparoscopy.a
Study (no. of patients) Definition of positive physical examination Anatomic site Sensitivity Specificity PPV NPV
Hudelist	et	al.	 
201133	(n=129)
“Palpable	nodule	or	thickened	area	or	a	palpable	
cystic	expansion	with	topographic-	anatomical	
correlation”
Ovary 41 99 92 87
Rectum	and/or	sigmoid 39 97 86 84
USL 50 80 43 84
Pouch	of	Douglas 76 92 64 95
Vagina 73 98 80 97
RVS 78 98 78 98
Bladder 25 100 100 98
Hudelist	et	al.	 
200934	(n=200)
“Palpable	nodularity	or	stiffened	and/or	
thickened	area	or	a	palpable	cystic	expansion	
with	topographic-	anatomical	correlation”
Right/left	ovary 38/23 99/99 90/75 92/90
Right/left	USL 52/74 97/89 67/65 94/93
Pouch	of	Douglas 70 98 84 95
Vagina 64 100 100 96
RVS 88 99 78 99
Bladder 25 100 100 98
Rectum 46 99 96 85
Bazot	et	al.	200935 
(n=92)b
Lesions	visualized	on	posterior	vaginal	fornix;	
infiltration	and/or	nodule	involving	the	vagina,	
torus	uterinus,	USL,	or	pouch	of	Douglas;	or	
infiltration	and/or	mass	involving	the	 
rectosigmoid	colon
USL 74 78 97 24
Vagina 50 87 65 78
RVS 18 96 40 90
Intestine 46 72 78 38
Abrao	et	al.	200736 
(n=104)b
Nodule	of	RVS;	thickening	or	nodule	in	the	USL	
or	cul-	de-	sac
Rectosigmoid 72 54 63 64
Retrocervical 68 46 45 69
Cheewadhanaraks	et	al.	
200437	(n=116)
Tenderness	and/or	nodularity	of	the	cul-	de-	sac	
or	USL
Cul-	de-	sac	and/or	USL NA NA 86–95c NA
Eskenazi	et	al.	200128 
(n=90)
USL	scarring,	nodularity	or	pain;	pouch	of	
Douglas	nodularity	or	pain;	vaginal	lesions;	
painful	or	fixed	adnexal	masses;	or	fixed	uterus	
and/or	pain	on	movement	of	uterus
Any 76 74 67 81
Abbreviations:	PPV,	positive	predictive	value;	NPV,	negative	predictive	value;	USL,	uterosacral	ligament;	RVS,	rectovaginal	septum;	NA,	not	applicable.
aValues	are	given	as	percentages.
bData	are	for	a	diagnosis	of	deep	endometriosis.
cValues	varied	depending	on	the	measure	used	(i.e.	tenderness,	nodularity,	or	tenderness	plus	nodularity).
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with	pelvic	examination	plus	TVUS.	Moreover,	endometriosis	of	the	
urinary	bladder,	which	was	detected	in	one	of	four	patients	via	physi-
cal	examination,	was	identified	in	three	of	four	patients	with	the	addi-
tion	of	TVUS.34
A	 strong	 correlation	 has	 been	 observed	 between	 TVUS	 mark-
ers	 and	 laparoscopic	findings.	Among	120	consecutive	women	with	
chronic	 pelvic	 pain	 evaluated	 by	 Okaro	 et	al.,38	 “hard	 markers”	 on	
TVUS	 (structural	 abnormalities	 such	 as	 endometriomas	 or	 hydro-
salpinges)	demonstrated	a	100%	correlation	 (24	of	24	women)	with	
laparoscopic	findings.	In	addition,	“soft”	markers	(e.g.	reduced	ovarian	
mobility,	site-	specific	pelvic	tenderness,	and	the	presence	of	loculated	
peritoneal	fluid	in	the	pelvis)	were	predictive	of	pelvic	pathology,	with	
37	of	51	 (73%)	of	women	with	only	soft	markers	by	TVUS	having	a	
true-	positive	result.	These	data	lend	support	to	an	empiric	course	of	
treatment,	 as	 61	 of	 75	 (81%)	women	 evaluated	 by	TVUS	 had	 their	
need	for	treatment	confirmed	laparoscopically.
TVUS	 is	generally	considered	 the	first-	line	 imaging	approach	 for	
evaluating	 suspected	 endometriosis.	 Professional	 society	 guidelines	
cite	its	utility	for	detecting	endometriosis	and/or	deep	endometriosis	
of	the	rectum	or	rectovaginal	septum,	and	in	diagnosing	or	excluding	
ovarian	endometrioma	(Table	1).1,8	Recent	evidence	suggests	that	the	
diagnostic	acumen	of	TVUS	for	deep	endometriosis	of	the	bowel	may	
be	increased	by	adding	bowel	preparation.39	However,	the	effective-
ness	of	TVUS	in	detecting	superficial	peritoneal	disease	is	extremely	
limited.	This	method	could,	therefore,	be	of	reduced	value	for	adoles-
cents	as	superficial	lesions	are	the	predominant	form	of	endometriosis	
in	this	population.40
4.2 | Magnetic resonance imaging
Owing	to	its	higher	costs	relative	to	other	imaging	modalities,	magnetic	
resonance	imaging	(MRI)	is	less	frequently	applied	for	the	assessment	
of	endometriosis.	However,	MRI	is	useful	in	cases	where	ultrasonog-
raphy	 findings	 are	 equivocal1,7	 and	 in	 carefully	 selected,	 high-	risk	
patients	 (e.g.,	 those	 with	 extensive	 pelvic	 adhesions	 of	 suspected	
ureteral	involvement).41	Nonetheless,	this	method	is	helpful	for	cases	
where	 ultrasonographic	 findings	 are	 equivocal1,7	 or	 for	 use	 among	
carefully	selected	high-	risk	patients	such	as	those	with	extensive	pel-
vic	adhesions	or	suspected	ureteral	involvement.41	One	advantage	of	
MRI	 is	 that	 interpretation	 of	 the	 results	 is	 less	 operator-	dependent	
compared	with	TVUS.42	As	shown	in	Table	1,	the	American	College	of	
Obstetricians	and	Gynecologists1	and	the	Society	of	Obstetricians	and	
Gynaecologists	of	Canada7	guidelines	support	selective	use	of	MRI	for	
cases	where	ultrasonographic	results	are	not	clear	regarding	rectovag-
inal	or	bladder	endometriosis1	and	if	deep	endometriosis	is	suspected.7
4.3 | Recommendations for imaging
Recommendations	for	the	use	of	imaging	modalities	differ	consider-
ably	among	professional	society	guidelines	and	consensus	statements	
(Table	1).	 The	 recommendations	 provided	 reflect	 the	 available	 evi-
dence	at	 the	time	when	each	document	was	developed,	 the	expert	
opinions	of	the	writing	committee	members,	and	the	questions	that	
these	committees	were	 seeking	 to	answer.	Hence,	 such	differences	
are	not	unexpected.	As	the	evidence	base	for	 imaging	modalities	 in	
the	diagnosis	of	endometriosis	grows,	 it	 is	 likely	 that	 increased	uni-
formity	and	strength	of	imaging	recommendations	will	emerge.
Estimates	of	the	accuracy	of	physical	examination,	with	or	without	
imaging,	 for	 identifying	 endometriosis	 must	 include	 the	 caveat	 that	
these	tools	are	compared	with	laparoscopic	visualization,	which	has	its	
own	limitations	(see	Section	5	below).	It	is	also	worth	noting	that	the	
studies	described	herein	have	not	quantified	the	accuracy	of	a	compre-
hensive	approach	to	diagnosis	that	 incorporates	patient	history,	pain	
features,	response	to	NSAIDs	or	oral	contraceptives,	characteristics	of	
the	menstrual	cycle,	physical	examination	findings,	and	imaging	studies.	
With	all	these	facets	of	disease	considered	in	totality,	a	more	precise	
clinical	picture	is	likely	to	emerge.	Studies	of	combinations	of	two	or	
three	noninvasive	tests	(often	involving	a	biomarker)	have	yet	to	meet	
the	criteria	for	a	replacement	test	for	diagnostic	surgery,	according	to	
a	recent	systematic	review.43	However,	using	a	combination	of	symp-
toms,	 clinical	 factors,	 and	 patient	 characteristics,	 Nnoaham	 et	al.32 
created	models	 that	had	 reasonable	accuracy	 for	predicting	stage	 III	
and	IV	disease	(yet	lacked	discriminatory	power	to	detect	stage	I	or	II	
disease).	Regardless,	the	true	value	of	a	clinical	diagnosis	might	not	rest	
solely	on	its	accuracy	versus	surgical	diagnosis,	but	rather	in	its	broad	
application	and	ability	to	allow	for	early	initiation	of	treatment.
5  | SURGICAL DIAGNOSIS  
OF ENDOMETRIOSIS
Laparoscopic	 visualization	 is	 the	 current	 standard	 for	 diagnosis	 of	
endometriosis.1,7,8	Reliance	on	this	method	for	endometriosis	detec-
tion	in	symptomatic	women	is	predicated	on	preoperative	selection	of	
women	with	a	high	pretest	likelihood	of	endometriosis	and	on	visual	
recognition	by	the	surgeon	of	a	full	range	of	potential	endometriosis	
lesions.	 Notably,	 endometriosis	 is	 not	 detected	 among	 one-	quarter	
of	women	who	undergo	a	laparoscopic	procedure	for	chronic	pelvic	
pain	and/or	suspected	endometriosis.44–46	Superficial	endometriosis	
lesions	present	a	particular	diagnostic	dilemma	for	physicians	owing	
to	 their	 heterogeneous	 visual	 appearance	 and	 the	 fact	 that	 non-	
pigmented	peritoneal	 lesions	often	represent	highly	active	endome-
triotic	implants.47	Visual	identification	is	compromised	by	the	myriad	
phenotypic	 appearances	 and	 pathologic	 characteristics	 (e.g.,	 endos-
alpingiosis,	mesothelial	hyperplasia,	hemosiderin	deposition,	heman-
giomas,	carbon	from	previous	laser	treatments)	of	lesions	that	can	be	
confused	with	endometriotic	implants.	In	addition,	endometriosis,	as	
defined	by	the	histologic	identification	of	stroma	and	glands,	may	be	
present	in	normal-	appearing	tissue.17	Such	is	the	case	for	microscopic	
lesions	that	reside	in	visually	normal	peritoneum.
A	definitive	diagnosis	of	endometriosis	has	traditionally	required	
histologic	 confirmation	 of	 disease	 after	 visualization	 of	 lesions.	
Standard	histologic	criteria	include	the	presence	of	at	least	two	of	the	
following:	endometrial	glands,	endometrial	stroma,	and	hemosiderin-	
laden	macrophages.	These	criteria	were	established	before	apprecia-
tion	of	the	prevalence	of	non-	blue	and/or	black	 lesions	and	without	
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understanding	of	the	natural	history	of	superficial	peritoneal	endome-
triosis	lesions.	As	shown	in	Table	4,	a	survey	of	studies	that	evaluated	
the	 accuracy	 of	 laparoscopic	 identification	 reveals	 that	 as	 many	 as	
67%	of	 lesions	considered	 to	be	endometriosis	on	visual	 inspection	
were	 not	 confirmed	 histologically.44–46,48–52	 The	 potential	 for	 false	
positives	was	generally	higher	at	stages	I	and	II	in	comparison	with	III	
and	IV,	although	there	is	an	apparent	decrease	in	PPV	between	stages	
III	and	IV.
Location	also	influences	the	diagnostic	accuracy	of	laparoscopic	
visualization	 when	 histology	 is	 considered	 as	 the	 gold	 standard.	
For	example,	Albee	et	al.50	 evaluated	 laparoscopic	visualization	of	
endometriosis	among	512	women	with	pelvic	pain.	These	investiga-
tors	found	that	the	accuracy	was	less	than	70%	for	lesions	located	
on	the	pelvic	sidewall,	uterosacral	ligament,	and	bladder.	The	NPVs	
for	 these	 locations	were	 39%–56%,	 suggesting	 a	 high	 degree	 of	
false-	negative	 results;	 these	 cases	 tended	 to	 be	 atypical	 lesions	
with	 endometriosis	 (defined	by	 the	presence	of	 both	 endometrial	
glands	and	stroma)	identified	only	by	histology.	However,	with	care-
fully	conducted	biopsy	procedures	and	selected	portions	of	speci-
mens	sent	for	pathologic	examination,	endometriosis	is	detected	in	
at	least	75%	of	biopsies.	Whether	biopsy	is	routinely	performed	and	
this	high	confirmation	 rate	 is	achieved	 in	clinical	practice	 remains	
to	be	determined.
Comparisons	 among	 studies	 also	 reveal	 considerable	 hetero-
geneity	 in	the	sensitivity,	specificity,	PPV,	and	NPV	of	 laparoscopic	
diagnosis	of	endometriosis	 (Table	4),	which	may	be	due,	 at	 least	 in	
part,	to	interobserver	variability.	This	phenomenon	can	compromise	
accurate	 diagnosis	 of	 endometriosis	 by	 laparoscopy.44	 Differences	
in	lesion	interpretation	and	staging	can	occur	among	laparoscopists	
and/or	pathologists	evaluating	biopsy	results.	 Interestingly,	a	study	
that	 evaluated	 inter-	rater	 agreement	 on	 endometriosis	 diagnosis	
and	staging	found	that	surgeons	and	expert	reviewers	demonstrated	
TABLE  4 Accuracy	of	laparoscopic	visualization	for	diagnosis	of	endometriosis.a,b
Study (no. of patients) Population Stage Sensitivity Specificity PPV NPV
Fernando	et	al.	201344	(n=431) Women	who	underwent	laparoscopic	biopsy	for	
suspected	endometriosis
All NA NA 75 NA
I NA NA 50 NA
II NA NA 80 NA
III NA NA 78 NA
IV NA NA 79 NA
Stegmann	et	al.	200845	(n=133) Women	who	underwent	laparoscopic	biopsy	for	
chronic	pelvic	pain
All 98 21 64 88
Kazanegra	et	al.	200846	(n=104) Women	who	underwent	laparoscopic	biopsy	for	
suspected	endometriosis
All NA NA 87 NA
I NA NA 76 NA
II NA NA 90 NA
III NA NA 100 NA
IV NA NA 91 NA
El	Bishry	et	al.	200848	(n=48) Women	who	underwent	laparoscopic	biopsy	for	
pelvic	pain
All NA NA 75 NA
I NA NA 33 NA
II NA NA 71 NA
III NA NA 92 NA
IV NA NA 73 NA
Almeida	Filho	et	al.	200849	(n=976) Women	who	underwent	laparoscopic	biopsy	for	
pelvic	pain	and/or	infertility
All 98 79 72 98
Albee	et	al.	200850	(n=512) Women	who	underwent	laparoscopic	biopsy	for	
pelvic	pain
All 62–100b 40–83c 71–94c 26–100c
Stratton	et	al.	200351	(n=48) Women	who	underwent	laparoscopic	biopsy	for	
pelvic	pain
All NA NA 86 NA
I NA NA 62 NA
II NA NA 100 NA
III NA NA 100 NA
IV NA NA 86 NA
Walter	et	al.	200152	(n=44) Women	who	underwent	laparoscopic	biopsy	for	
chronic	pelvic	pain
All 97 77 45 99
Abbreviations:	PPV,	positive	predictive	value;	NPV,	negative	predictive	value;	NA,	not	applicable.
aValues	are	given	as	percentage.
bEndometriosis	was	confirmed	by	histologic	evidence	of	both	endometrial	glands	and	stroma	for	all	studies	except	Almeida	Filho	et	al.	49	(in	which	the	
presence	of	glands	and	stroma	was	not	specified)	and	Stratton	et	al.	51	(in	which	the	presence	of	endometrial	glands	or	stroma	was	required).
cRanges	reflect	differences	depending	on	the	anatomic	location	of	the	lesion.
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high	levels	of	agreement	when	viewing	digital	images	of	laparoscopic	
findings	or	operative	reports.53	However,	agreement	decreased	con-
siderably	 after	 viewing	 histologic	 findings.	 These	 results	 highlight	
potential	 differences	 in	 interpretation	 among	 laparoscopists	 and	
pathologists	that	are	further	obscured	by	ambiguities	and	differences	
in	the	available	staging	systems.
Laparoscopic	 surgery,	 with	 or	 without	 lesion	 biopsy	 for	 histo-
logic	confirmation,	is	intrinsically	associated	with	an	increased	risk	of	
intraoperative	injury	such	as	vascular	injury,	bowel	or	bladder	perfo-
ration,	and	damage	to	the	ureter.7,8	Complications	of	anesthesia	can	
also	occur.	Major	 or	minor	 adverse	 events	 arising	 from	 laparoscopy	
are	 found	 in	 an	 estimated	 8.9%	 of	 all	 procedures.54	 Even	 though	
this	rate	represents	the	minority	of	cases,	 it	should	be	factored	 into	
the	risk-	to-	benefit	equation	and	weighed	against	the	risks	of	 initiat-
ing	 treatment	without	a	surgical	diagnosis	or	delaying	 the	discovery	
of	 non-	endometriosis	 pathology	when	 determining	 the	 appropriate	
course	of	management	for	an	individual	patient.
6  | RECOMMENDATIONS FOR  
RESHAPING THE DIAGNOSIS  
OF ENDOMETRIOSIS
Despite	 limitations	 in	 the	 knowledge	 and	 evidence	 base	 regarding	
endometriosis—from	the	most	basic	understanding	of	disease	patho-
genesis	through	to	its	diagnosis	and	management—the	present	clinical	
need	demands	that	we	consider	how	to	optimize	the	information	and	
approaches	available	 to	us	so	as	 to	provide	cost-	effective	 interven-
tions	for	patients.	To	that	end,	we	have	developed	several	recommen-
dations	to	increase	the	understanding	of	endometriosis	and	promote	
its	accurate	and	timely	diagnosis	that	could	be	meritorious	and	worthy	
of	future	study.
6.1 | Short- term suggestions
In	our	opinion,	significant	advances	for	patients	could	be	achieved	
by	 improving	 and	 quantifying	 the	 value	 of	 nonsurgical	 diagnosis	
of	 symptomatic	 endometriosis.	 Our	 approach	 to	 the	 question	 of	
surgical	 versus	 clinical	 diagnosis	 of	 symptomatic	 endometriosis,	
though	informative	and	based	on	clinical	evidence,	should	be	con-
sidered	hypothesis-	generating.	We	see	the	next	step	in	reconciling	
this	 query	 to	 be	 a	 collaboration	 among	 professional	 societies	 to	
analyze	 the	data	 critically	 and	 introduce	quantitative	 approaches	
to	 diagnosis.	 This	 undertaking	 would	 involve	 multiple	 areas	 of	
	investigation	(Box	1).
At	 the	 most	 rudimentary	 level,	 development	 of	 an	 algorithm	
based	 on	 clinical	 evaluations	 that	 could	 identify	 patients	 with	 the	
greatest	 likelihood	of	endometriosis	who	are,	 therefore,	 candidates	
for	 further	 evaluation	would	 be	 of	 considerable	value	 to	 clinicians,	
both	in	primary	care	and	gynecologic	practice.	A	paradigm	for	early	
evaluation	and	diagnosis	would	be	particularly	useful	to	primary	care	
physicians,	who	are	often	the	first	point	of	contact	for	patients	with	
symptoms	of	endometriosis.61
6.2 | Long- term needs and opportunities
Increased	 understanding	 of	 the	 natural	 history	 of	 endometriosis	
as	 it	 relates	 to	 symptom	 development	 and	 presentation	 (e.g.	 pain,	
menstrual	 anomalies,	 gastrointestinal	 symptoms,	 fatigue,	 bloating,	
and	paresthesia)	would	help	clinicians	to	differentiate	endometriosis	
from	other	conditions	 that	share	symptomology.	This	 type	of	 infor-
mation	 is	best	gleaned	through	clinical	studies	that	examine	patient	
experiences	with	 symptoms	and	how	 they	vary	with	time,	age,	 and	
menstrual	 cycle.	 Comparative	 data,	 collected	 from	 patient	 diaries,	
could	be	gathered	 from	women	with	 and	without	 endometriosis	 to	
determine	how	the	type,	frequency,	and	severity	of	symptoms	differ	
between	these	two	groups,	with	further	analysis	by	demographic	and	
B O X  1  Improving	Endometriosis	Diagnosis:	Topics	for	
Future	Research	and	Development
•	 An	 assessment	 of	 response	 to	 first-line	 therapy	 (over-the-
counter	analgesics,	NSAIDs,	and	oral	 contraceptives)	as	an	
indicator	of	endometriosis.	The	fundamental	question	here	is	
whether	response,	or	lack	thereof,	is	indicative	of	endome-
triosis.	Variables	such	as	complete	response,	partial	response,	
and	the	time	course	of	changes	in	pain	and/or	other	symp-
toms	should	be	included	in	the	evaluation.
•	 A	quantitative	analysis	of	the	contribution	of	imaging	modali-
ties	to	the	diagnosis	of	endometriosis.	The	value	of	both	hard	
and	soft	markers	should	be	evaluated,	and	the	interobserver	
reliability	of	these	markers	among	practitioners	assessed.
•	 Embarking	on	studies	that	increase	understanding	of	the	risk	
of	disease	progression	among	women	with	untreated	endo-
metriosis.	Although	a	diagnostic	delay	of	7	years	or	 longer	
has	been	well	documented,2,4,5	there	are	few	data	to	objec-
tively	validate	the	perspective	that	early	accurate	diagnosis	
and	initiation	of	treatment	improve	long-term	outcomes	(e.g.	
fertility,	 relief	 of	 chronic	pain,	 reduced	 risk	of	 clear	 cell	 or	
endometrioid	 ovarian	 carcinoma,	 and	 fewer	 cases	 of	 pre-
eclampsia	 and	 preterm	 delivery).55–58	 Nonetheless,	 expert	
opinion	and	clinical	experience	support	the	plausibility	that	
early	diagnosis	will	reduce	long-term	morbidity.59	The	argu-
ment	 for	 early	 diagnosis	 is	 further	 strengthened	 by	 the	
observation	 that	 advanced-stage	 disease	 is	more	 common	
among	young	women	than	has	been	typically	appreciated.60 
To	assess	the	question	of	the	clinical	value	of	early	diagnosis	
in	 the	 prevention	 of	 endometriosis-related	 sequelae,	 data	
mining	can	be	applied	to	existing	repositories,	such	as	medi-
cal	 insurance	 claims	 databases	 and	 electronic	 medical	
records.	However,	the	most	definitive	data	would	be	derived	
from	rigorous	longitudinal	studies.
•	 Establishing	criteria	and	paradigms	for	clinical,	visual,	and	his-
tologic	diagnosis	of	endometriosis	that	consider	patient	pref-
erences,	 cost-effectiveness,	 and	ease	of	 implementation	 in	
clinical	practice.
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clinical	parameters	such	as	current	age	and	symptom	history.	Studies	
measuring	the	response	of	symptoms	to	first-	line	therapies	in	various	
patient	groups	could	also	prove	informative	for	differential	diagnosis	
(e.g.	relief	of	pain	among	women	with	primary	dysmenorrhea	versus	
dysmenorrhea	due	to	endometriosis).	Nomograms	of	symptoms	could	
then	 be	 developed	 from	 these	 data	 to	 illustrate	 the	 differences	 in	
symptomology	 among	 women	with	 endometriosis,	 women	without	
endometriosis,	and	women	with	other	gynecologic	conditions.
Understanding	 disease	 pathogenesis	 is	 also	 a	 first	 step	 to	 bio-
marker	development.	To	date,	no	single	biomarker	or	combination	of	
biomarkers	 (e.g.	 endometrial,	 blood-	based,	 or	 urinary)	 has	 emerged	
as	 the	 standard	 for	 diagnosis	 of	 endometriosis.62–65	 The	 lack	 of	 a	
definitive	 biomarker	 is	 not	 an	 indictment	 of	 those	 that	 have	 been	
studied,	 rather	 it	 reflects	 the	 state	 of	 the	 available	 evidence,	which	
is	constrained	by	studies	with	small	sample	sizes	and	other	method-
ological	limitations.	Indeed,	we	believe	that	the	future	of	biomarkers	
is	strong,	as	evidenced	by	their	widespread	use	in	other	fields	of	med-
icine	and	the	multitude	of	investigations	that	have	already	identified	
several	 promising	 biomarkers	 for	 endometriosis.66–68	 Development	
of	 biomarkers	 in	 the	 context	 of	 endometriosis	 would	 be	 bolstered	
by	well-	designed	studies	that	include	biomarkers	in	conjunction	with	
other	clinical	diagnostic	measures.	The	World	Endometriosis	Research	
Foundation	 Endometriosis	 Phenome	 and	Biobanking	Harmonisation	
Project	 is	making	progress	 toward	enhanced	understanding	 through	
global	research	collaboration.69–72
7  | CONCLUSION
The	present	investigation	of	diagnostic	modalities	for	endometriosis	
has	resulted	in	several	important	conclusions.	First,	there	is	consider-
able	opportunity	 to	 reduce	 the	time	 to	diagnosis	 for	 a	disease	 that	
creates	a	major	quality-	of-	life	burden	for	many	affected	 individuals.	
Second,	a	clinical	diagnosis	could	have	distinct	value	because	it	is	non-
invasive	and	based	on	simple	 techniques	 that	are	generally	 routine;	
available	to	both	primary	care	and	subspecialty	clinicians;	and	can	be	
broadly	applied	without	appreciable	alterations	to	standard	practices	
and	patient	flow.	On	a	global	scale,	a	simple	clinical	approach	to	diagno-
sis	could	have	wide	application	in	low-	resource	settings.	Indeed,	WES	
recommends	that	diagnosis	of	endometriosis	in	such	settings	should	
begin	with	 “two	 simple	 questions	 about	 pelvic-	abdominal	 pain	 and	
infertility”.11	Advancing	this	idea	to	include	further	resource-	sparing,	
but	informative,	assessments	is	another	step	forward	in	patient	care.	
Third,	we	have	yet	to	quantify	the	accuracy	of	combining	biomarkers	
and	other	objective	 indicators	of	disease	with	physical	 examination	
and	 imaging	findings	as	constituents	of	a	comprehensive	diagnostic	
paradigm.	Fourth,	when	considered	objectively,	 surgical	diagnosis	 is	
neither	clearly	superior	nor	more	accurate	than	clinical	diagnosis,	as	
many	clinicians	have	been	taught	to	believe.	Indeed,	this	perception	is	
a	product	of	focus	on	a	visually	or	histologically	defined	lesion	as	the	
disease,	 to	 the	 exclusion	of	 the	 symptomatic	presentation.	 In	 addi-
tion	to	accuracy,	issues	of	access	to	care	(from	an	economic	and	geo-
graphic	perspective)	and	surgical	risk	also	must	be	factored	into	the	
paradigm	for	diagnosis	of	symptomatic	endometriosis.	Finally,	 initia-
tion	of	endometriosis	treatment	should	not	be	predicated	on	a	surgi-
cal	diagnosis.	In	practice	(and	in	accordance	with	clinical	guidelines),	
empiric	 therapy	 is	 appropriate	 for	 patients	 whose	 symptoms	 and	
clinical	evaluation	are	consistent	with	endometriosis	(e.g.	women	with	
cyclic	progressive	pelvic	pain	not	attributable	to	other	conditions).
The	 potential	 for	 clinical	 diagnosis	 of	 symptomatic	 endometrio-
sis	does	not	negate	 the	value	of	 laparoscopy	nor	does	 it	mean	 that	
laparoscopy	will	 not	 be	 eventually	 required	 for	 a	 subset	 of	 patients	
diagnosed	clinically.	Surgical	intervention	remains	a	valuable	manage-
ment	option	for	cases	where	medical	therapy	does	not	provide	suffi-
cient	symptom	relief	or	when	scarring	could	be	present.	This	approach	
also	allows	pathologic	and/or	histologic	validation	of	the	diagnosis.	In	
addition,	there	are	patients	for	whom	laparoscopy	could	be	beneficial	
before	implementation	of	medical	therapy,	such	as	cases	where	a	mass	
is	detected	on	clinical	evaluation,	malignancy	 is	 suspected,	or	when	
the	diagnosis	is	unclear.
Ultimately,	regardless	of	individual	opinions	or	preferences	regard-
ing	clinical	versus	surgical	diagnosis,	our	common	goal	is	to	accelerate	
recognition	 of	 symptomatic	 endometriosis	 so	 that	we	 can	 increase	
access	to	appropriate	and	effective	management	options	and	reduce	
the	burden	of	disease.
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